Literature DB >> 30896985

Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain.

Andrew H Rogers1, Brooke Y Kauffman1, Jafar Bakhshaie1, R Kathryn McHugh2, Joseph W Ditre3, Michael J Zvolensky1,4,5.   

Abstract

Background: The opioid epidemic is a significant public health crisis, and this problem is particularly prevalent among individuals with chronic pain. Accordingly, there is an urgent need for interventions to mitigate the risk for opioid misuse and opioid use disorder among people with pain. Given that mental health problems, specifically anxiety, are common among people who misuse opioids, it is important to examine factors that link mental health problems with opioid misuse to ultimately inform the development of novel interventions. Anxiety sensitivity, a transdiagnostic vulnerability factor defined as the fear of anxiety-related physical sensations, may be one important mechanism in elevated opioid misuse among persons with chronic pain. Objective: Therefore, the current cross-sectional study examined anxiety sensitivity (and construct sub-facets) as a predictor of opioid misuse among adults with chronic pain. Method: Adults reporting chronic pain and prescription opioid use completed an online survey.
Results: Anxiety sensitivity was associated with multiple aspects of opioid misuse, including current opioid misuse, severity of opioid dependence, and number of opioids used to get high. The magnitude of effects ranged from medium to large. Associations between anxiety sensitivity and opioid misuse were observed over and above the variance accounted for by age, sex, income, education, perceived health, and pain severity.
Conclusion: These findings suggest that anxiety sensitivity may be an important treatment target among adults with chronic pain who misuse opioids. Future research should continue to explore the explanatory relevance of anxiety sensitivity in opioid misuse among individuals with chronic pain.

Entities:  

Keywords:  Opioid misuse; anxiety sensitivity; chronic pain; comorbidity; transdiagnostic

Year:  2019        PMID: 30896985      PMCID: PMC7137151          DOI: 10.1080/00952990.2019.1569670

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  47 in total

Review 1.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain.

Authors:  R Kathryn McHugh; Roger D Weiss; Marise Cornelius; Marc O Martel; Robert N Jamison; Robert R Edwards
Journal:  J Pain       Date:  2016-04-04       Impact factor: 5.820

3.  The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.

Authors:  M Gossop; S Darke; P Griffiths; J Hando; B Powis; W Hall; J Strang
Journal:  Addiction       Date:  1995-05       Impact factor: 6.526

4.  Refinement of a brief anxiety sensitivity reduction intervention.

Authors:  Meghan E Keough; Norman B Schmidt
Journal:  J Consult Clin Psychol       Date:  2012-04-02

5.  Detecting and monitoring depression with a two-item questionnaire (PHQ-2).

Authors:  Bernd Löwe; Kurt Kroenke; Kerstin Gräfe
Journal:  J Psychosom Res       Date:  2005-02       Impact factor: 3.006

6.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

7.  Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Patrick O Monahan; Bernd Löwe
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

8.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

9.  Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy.

Authors:  Marc O Martel; Patrick H Finan; R Kathryn McHugh; Mohammed Issa; Robert R Edwards; Robert N Jamison; Ajay D Wasan
Journal:  Drug Alcohol Depend       Date:  2016-03-18       Impact factor: 4.492

10.  Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.

Authors:  C W Lejuez; Michael J Zvolensky; Stacey B Daughters; Marina A Bornovalova; Autumn Paulson; Matthew T Tull; Kenneth Ettinger; Michael W Otto
Journal:  Behav Res Ther       Date:  2008-03-28
View more
  9 in total

1.  The Interaction of Alcohol Use and Cannabis Use Problems in Relation to Opioid Misuse Among Adults with Chronic Pain.

Authors:  Andrew H Rogers; Justin M Shepherd; Daniel J Paulus; Michael F Orr; Joseph W Ditre; Jafar Bakhshaie; Michael J Zvolensky
Journal:  Int J Behav Med       Date:  2019-10

2.  Anxiety and depressive symptoms among adults with obesity and chronic pain: the role of anxiety sensitivity.

Authors:  Brooke Y Kauffman; Andrew H Rogers; Lorra Garey; Michael J Zvolensky
Journal:  Cogn Behav Ther       Date:  2022-01-10

3.  The Impact of the First Wave of the COVID-19 Pandemic on Patients' Perceptions of Chronic Pain.

Authors:  Maria Eleni Smyrnioti; Georgios Lyrakos; Maria Meindani; Paraskevi Matsota; Georgia Kostopanagiotou; Chrysanthi Batistaki
Journal:  J Pain Res       Date:  2021-08-21       Impact factor: 3.133

4.  Emotion dysregulation, fatigue, and electronic cigarette expectancies.

Authors:  Michael J Zvolensky; Kara Manning; Lorra Garey; Candice A Alfano; Nubia A Mayorga; Natalia Peraza
Journal:  Cogn Behav Ther       Date:  2020-10-02

5.  Increased Experimental Pain Sensitivity in Chronic Pain Patients Who Developed Opioid Use Disorder.

Authors:  Peggy A Compton; Thomas E Wasser; Martin D Cheatle
Journal:  Clin J Pain       Date:  2020-09       Impact factor: 3.423

6.  Doctor shopping among chronic noncancer pain patients treated with opioids in the province of Quebec (Canada): incidence, risk factors, and association with the occurrence of opioid overdoses.

Authors:  Jean-Luc Kaboré; M Gabrielle Pagé; Lise Dassieu; Éric Tremblay; Mike Benigeri; Denis A Roy; Anaïs Lacasse; Manon Choinière
Journal:  Pain Rep       Date:  2021-09-16

Review 7.  Cognitive-Affective Transdiagnostic Factors Associated With Vulnerability to Alcohol and Prescription Opioid Use in the Context of Pain.

Authors:  Emily L Zale; Jessica M Powers; Joseph W Ditre
Journal:  Alcohol Res       Date:  2021-07-15

8.  Lack of Premeditation Predicts Aberrant Behaviors Related to Prescription Opioids in Patients with Chronic Pain: A Cross-Sectional Study.

Authors:  Gabrielle Hettie; Chinwe Nwaneshiudu; Maisa S Ziadni; Beth D Darnall; Sean C Mackey; Dokyoung S You
Journal:  Subst Use Misuse       Date:  2021-08-09       Impact factor: 2.362

Review 9.  The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.

Authors:  Isabell M Meier; Marie Eikemo; Siri Leknes
Journal:  Curr Addict Rep       Date:  2021-04-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.